SARS-CoV2 – Page 43 – Communicable Diseases Research

Teicoplanin—A New Use for an Old Drug in the COVID-19 Era?

Review

Published on 2021-11-262022-10-28
Journal: Pharmaceuticals [Category] COVID-19,

Implementing Lung Ultrasound in the Outpatient Management of COVID-19 Pneumonia: A Pilot Study to Update Local Guidelines

Medicine

Published on 2021-11-262022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] age ambulatory patient approach assessment calculated chest X-ray clinical examination clinician conducted COVID-19 COVID-19 pandemic demographics Descriptive statistics Diagnosis died distribution evaluate Follow-up guideline help Hospitalization Hospitalized Implementing IMPROVE Inclusion Local lung management means men Mild-to-moderate outcome Outpatient pandemic Patient percentages performed Pneumonia presenting Prospective Study protocol random reduce SARS-CoV2 Sensitivity and specificity severity and prognosis single-center Standard deviation Switzerland Ultrasound variables with COVID-19
[DOI] 10.3389/fmed.2021.774035 PMC 바로가기 [Article Type] Medicine

An overview of the National COVID-19 Chest Imaging Database: data quality and cohort analysis

Data Note

Published on 2021-11-252022-10-31
Journal: GigaScience [Category] COVID-19, MERS, SARS,

Sex-Specific Microglial Activation and SARS-CoV-2 Receptor Expression Induced by Chronic Unpredictable Stress

Neuroscience

Published on 2021-11-242022-10-31
Journal: Frontiers in Cellular Neuroscience [Category] COVID-19,

Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program

Conference abstract

Published on 2021-11-232022-10-05
Journal: Blood [Category] 유전자 메커니즘, 임상, 치료법,

[키워드] acceleration AML Analysis Asymptomatic BMS board Celgene Chemotherapy clinical clinical study clinical trial Cohort cohort of patient concerning conducted Coronavirus disease 2019 cough COVID-19 COVID-19 infection cure death defined determine Diagnosis disease download education employment estimate exacerbated Exploratory analysis Fever figure Follow-up funding Hematological malignancy higher risk hospital immune response Immunosuppression incidence incidence of COVID-19 increasingly indicate Infection information intensity Intensive Jazz MDs median age myelodysplasia myeloid Non-COVID-19 Occurrence outcome pandemic Patient patient hospitalization patients patients treated Patients with cancer PCR test positive presenting symptom Program proportion Prospective provide receiving recruited reduce regimen regimens required Result resulting risk of COVID-19 risk of death SARS-CoV2 secondary severity speaker suffered Support table Takeda tested treated patients Treatment treatment arm treatment history vaccination venetoclax were infected
[DOI] 10.1182/blood-2021-146061 [Article Type] Conference abstract

Autoimmune Cytopenias and Covid-19 Vaccination: Relapse and Suggested Treatment

Conference abstract

Published on 2021-11-232022-10-05
Journal: Blood [Category] 치료법,

Saliva is superior over nasopharyngeal swab for detecting SARS-CoV2 in COVID-19 patients

타액은 COVID-19 환자에서 SARS-COV2를 감지하기 위해 비 인두 면봉보다 우수합니다.

Comparative Study

Published on 2021-11-222022-09-01
Journal: Scientific Reports [Category] MERS, SARS, 진단, 치료기술,

Impact of COVID-19 and lockdowns on pulmonary embolism in hospitalized patients in France: a nationwide study

Research

Published on 2021-11-202022-10-28
Journal: Respiratory Research [Category] COVID-19, MERS,

Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19

Commentary

Published on 2021-11-182022-10-30
Journal: Journal of Anesthesia, Analgesia and Critical Care [Category] COVID-19,

Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study

Article

Published on 2021-11-182022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] age antibody azathioprine BNT162b2 clinical trial Combination combination therapy Concentration control group COVID-19 COVID-19 vaccination COVID-19 vaccine dose evaluate excluded group healthy IBD IgA IgA level IgA levels IgG immunogenicity Inflammatory bowel disease infliximab IQR median mRNA vaccine multicenter neutralizing antibody of BNT162b2 outcomes participant Participants Patient patients treated percentage positive Primary outcome Prospective Prospective Study PROTECT receiving recruited SARS-CoV-2 antibody SARS-CoV2 seroconverted Serologic response Sex significantly lower study group the study group the vaccine vaccination Vaccine
[DOI] 10.3390/jcm10225362 PMC 바로가기 [Article Type] Article